**INTRODUCTION:** Indocyanine Green (ICG) angiography was first used in breast reconstruction in 2007 and has gained popularity due to its ability to assess the viability of both mastectomy skin and tissue flaps. We aim to analyze trends, disparities and outcomes associated with the use of ICG in breast reconstruction.

**METHODS:** Using 2012 - 2014 data from the National Inpatient Sample, breast reconstruction cases that were performed with or without the use of ICG angiography (International Classification of Diseases: Ninth Revision code 17.71). Trends over time in ICG use were assessed using the Cochran-Armitage test. Outcomes of interest included reconstruction modality, debridement rates, hospital charges and length of stay (LOS). Hospital charges and LOS were assessed using a generalized linear model with log link and gamma distribution.

**RESULTS:** Overall, 110,320 patients underwent breast reconstruction over the study period: 107,005 (97.0 percent) without the use of ICG and 3,315 (3.0 percent) with the use of ICG. ICG use increased over time: 750 patients (1.9 percent) underwent breast reconstruction with ICG in 2012, increasing to 1,275 patients (3.7 percent) in 2013 (p\<0.001). Black and Hispanic patients were more likely than White patients to undergo ICG use (p\<0.001). Smokers (p=0.018), hypertensive (p=0.046), obese patients (p\<0.001) and those with a higher comorbidity index (p\<0.001) were more likely to undergo ICG use. Large bed size hospitals (p\<0.001), teaching hospitals (p\<0.001) and Southern region (p\<0.001) had significantly greater use of ICG. It was more frequently used in autologous reconstruction as compared with tissue expander reconstruction (4.5 percent versus 2.1 percent; p\<0.001). There were significantly more debridements performed in cases where ICG was used (5.6 percent versus 3.2 percent; p\<0.001). Use of ICG added a mean charge of \$9,080 per reconstruction (\$79,242 vs. \$70,162; p\<0.001); however, it also resulted in a decreased LOS (2.37 days versus 2.47 days; p\<0.001).

**CONCLUSION:** The use of Indocyanine Green angiography in breast reconstruction has increased in recent years and is associated with higher debridement rates. Significant hospital, patient and ethnic disparities exist in Indocyanine Green angiography use. Although length of stay was significantly reduced statistically, it bears minimal clinical significance and clinicians may utilize this information regarding resource utilization in the setting of Indocyanine Green angiography use versus need for future additional unplanned procedures, given the significant increase in charges.
